CLINICAL CHARACTERISTICS OF COMMON PCSK9 GAIN-OF-FUNCTION E32K VARIANT WITH HIGHER TG ELEVATION, AND DOUBLE HETEROZYGOTES WITH COMMON PCSK9 VARIANTS AND LDLR MUTATIONS

被引：0
|
作者：
Nohara, A. [1 ]
Kawashiri, M. A. [2 ]
Tada, H. [2 ]
Yoshida, M. [1 ]
Mori, M. [2 ]
Nakanishi, C. [2 ]
Yagi, K. [3 ]
Inazu, A. [4 ]
Yamagishi, M. [2 ]
Mabuchi, H. [1 ]
机构：
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Adv Res Community Med, Kanazawa, Ishikawa, Japan
[2] Kanazawa Univ, Grad Sch Med Sci, Dept Cardiol, Kanazawa, Ishikawa, Japan
[3] Kanazawa Univ, Grad Sch Med Sci, Med Educ Res Ctr, Kanazawa, Ishikawa, Japan
[4] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa, Japan
来源：
ATHEROSCLEROSIS | 2016年 / 252卷
关键词：
D O I：
10.1016/j.atherosclerosis.2016.07.346
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS16-0802
引用
收藏
页码：E35 / E35
页数：1
相关论文
共 17 条
  • [1] The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation
    Noguchi, Tohru
    Katsuda, Shoji
    Kawashiri, Masa-aki
    Tada, Hayato
    Nohara, Atsushi
    Inazu, Akihiro
    Yamagishi, Masakazu
    Kobayashi, Junji
    Mabuchi, Hiroshi
    ATHEROSCLEROSIS, 2010, 210 (01) : 166 - 172
  • [2] PROFILES OF GAIN-OF-FUNCTION PCSK9 E32K MUTATION: INCLUDING PURE HOMOZYGOTE AND COMPOUND HETEROZYGOTE WITH LDLR GENE MUTATION
    Noguchi, T.
    Katsuda, S.
    Kawashiri, M-a
    Nohara, A.
    Kobayashi, J.
    Inazu, A.
    Takata, M.
    Tsuchida, M.
    Tada, H.
    Nakanishi, C.
    Yamagishi, M.
    Mabuchi, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [3] LIPOPROTEIN(A) IN FAMILIAL HYPERCHOLESTEROLEMIA WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS
    Tada, Hayato
    Kawashiri, Masa-Aki
    Nohara, Atsushi
    Inazu, Akihiro
    Mabuchi, Hiroshi
    Yamagishi, Masakazu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1896 - 1896
  • [4] EFFICACY OF EVOLOCUMAB (AMG 145) IN PATIENTSWITH PCSK9 GAIN-OF-FUNCTION MUTATIONS
    Harada-Shiba, M.
    Kishimoto, I.
    Makino, H.
    Ogura, M.
    Kurtz, C.
    Honarpour, N.
    Xu, F.
    Wasserman, S. M.
    Watts, G. F.
    ATHEROSCLEROSIS, 2014, 235 (02) : E11 - E11
  • [5] Prevalence, Clinical Characteristics and Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia Patients With Double-Heterozygous Mutation of LDLR and PCSK9 Gain-Of-Function Mutation
    Doi, Takahito
    Hori, Mika
    Harada-Shiba, Mariko
    Kataoka, Yu
    Nishikawa, Ryo
    Tsuda, Kosuke
    Nishimura, Kunihiro
    Ogura, Masatsune
    Noguchi, Teruo
    Yasuda, Satoshi
    CIRCULATION, 2018, 138
  • [6] Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations
    Tada, Hayato
    Kawashiri, Masa-aki
    Yoshida, Taiji
    Teramoto, Ryota
    Nohara, Atsushi
    Konno, Tetsuo
    Inazu, Akihiro
    Mabuchi, Hiroshi
    Yamagishi, Masakazu
    Hayashi, Kenshi
    CIRCULATION JOURNAL, 2016, 80 (02) : 512 - +
  • [7] Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia
    Abifadel, Marianne
    Guerin, Maryse
    Benjannet, Suzanne
    Rabes, Jean-Pierre
    Le Goff, Wilfried
    Julia, Zelie
    Hamelin, Josee
    Carreau, Valerie
    Varret, Mathilde
    Bruckert, Eric
    Tosolini, Laurent
    Meilhac, Olivier
    Couvert, Philippe
    Bonnefont-Rousselot, Dominique
    Chapman, John
    Carrie, Alain
    Michel, Jean-Baptiste
    Prat, Annik
    Seidah, Nabil G.
    Boileau, Catherine
    ATHEROSCLEROSIS, 2012, 223 (02) : 394 - 400
  • [8] Loss- and Gain-of-function PCSK9 Variants CLEAVAGE SPECIFICITY, DOMINANT NEGATIVE EFFECTS, AND LOW DENSITY LIPOPROTEIN RECEPTOR (LDLR) DEGRADATION
    Benjannet, Suzanne
    Hamelin, Josee
    Chretien, Michel
    Seidah, Nabil G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (40) : 33745 - 33755
  • [9] Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding
    Sarkar, Samantha K.
    Matyas, Angela
    Asikhia, Ikhuosho
    Hu, Zhenkun
    Golder, Mia
    Beehler, Kaitlyn
    Kosenko, Tanja
    Lagace, Thomas A.
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [10] Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations
    Martin, Rosalind
    Latten, Mark
    Hart, Padraig
    Murray, Helena
    Bailie, Deborah A.
    Crockard, Martin
    Lamont, John
    Fitzgerald, Peter
    Graham, Colin A.
    ATHEROSCLEROSIS, 2016, 254 : 8 - 13
12